首页> 美国卫生研究院文献>Healthcare >Negative Pressure Wound Therapy on Surgical Site Infections in Women Undergoing Elective Caesarean Sections: A Pilot RCT
【2h】

Negative Pressure Wound Therapy on Surgical Site Infections in Women Undergoing Elective Caesarean Sections: A Pilot RCT

机译:进行选择性剖宫产的女性手术部位感染的负压伤口治疗:RCT试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obese women undergoing caesarean section (CS) are at increased risk of surgical site infection (SSI). Negative Pressure Wound Therapy (NPWT) is growing in use as a prophylactic approach to prevent wound complications such as SSI, yet there is little evidence of its benefits. This pilot randomized controlled trial (RCT) assessed the effect of NPWT on SSI and other wound complications in obese women undergoing elective caesarean sections (CS) and also the feasibility of conducting a definitive trial. Ninety-two obese women undergoing elective CS were randomized in theatre via a central web based system using a parallel 1:1 process to two groups i.e., 46 women received the intervention (NPWT PICO™ dressing) and 46 women received standard care (Comfeel Plus® dressing). All women received the intended dressing following wound closure. The relative risk of SSI in the intervention group was 0.81 (95% CI 0.38–1.68); for the number of complications excluding SSI it was 0.98 (95% CI 0.34–2.79). A sample size of 784 (392 per group) would be required to find a statistically significant difference in SSI between the two groups with 90% power. These results demonstrate that a larger definitive trial is feasible and that careful planning and site selection is critical to the success of the overall study.
机译:进行剖腹产(CS)的肥胖妇女手术部位感染(SSI)的风险增加。负压伤口疗法(NPWT)作为预防SSI等伤口并发症的预防方法正在日益普及,但几乎没有证据表明其益处。这项试验性随机对照试验(RCT)评估了NPWT对接受选择性剖宫产(CS)的肥胖妇女的SSI和其他伤口并发症的影响,以及进行确定性试验的可行性。接受择期CS训练的92名肥胖女性通过基于中央网络的系统,采用平行1:1流程随机分配到两组中,即46名女性接受了干预(NPWT PICO™敷料),46名女性接受了标准护理(Comfeel Plus ®敷料)。伤口闭合后,所有妇女均接受了预期的敷料。干预组SSI的相对风险为0.81(95%CI 0.38–1.68);除SSI以外,并发症的发生率为0.98(95%CI 0.34–2.79)。要获得两组具有90%功效的SSI在统计上有显着差异,将需要样本量为784(每组392)。这些结果表明,更大的确定性试验是可行的,并且仔细的计划和选址对于整个研究的成功至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号